MELD 3.0 Score Interpretation

Understanding MELD 3.0 Score Range

The MELD 3.0 score operates on a continuous scale with a minimum score of 6, representing the lowest detectable severity of liver disease based on laboratory parameters, and correlates with 3-month mortality, ranging from approximately 90% survival at MELD 6 to 7% survival at MELD 40 1
The American Association for the Study of Liver Diseases recommends using the MELD 3.0 score to assess the severity of liver disease, with scores ranging from 6 to 40, and correlates with mortality risk 1

The MELD 3.0 score incorporates serum bilirubin, international normalized ratio (INR), serum creatinine, serum albumin, and patient sex to predict mortality risk in patients with liver disease, with women receiving approximately 1.3 additional points 2, 3
The European Association for the Study of the Liver recommends using the MELD 3.0 score, which includes serum albumin and patient sex, to improve mortality prediction and reduce gender disparities in liver transplant allocation 2, 3

Patients with MELD scores <15 are considered lower risk and typically do not meet criteria for liver transplant listing, requiring management focused on complications of cirrhosis rather than urgent transplant evaluation 4
The American College of Gastroenterology recommends regular monitoring for patients with MELD scores <15 to detect disease progression 4

MELD 3.0 was specifically developed to improve mortality prediction and reduce gender disparities in liver transplant allocation, showing better discrimination than MELD-Na, with a concordance statistic of 0.869 vs 0.862 2, 3

The American Association for the Study of Liver Diseases recommends using MELD 3.0, which incorporates serum albumin and patient sex as new variables to better predict 90-day mortality in patients with end-stage liver disease, particularly addressing sex-based disparities 5, 6, 7

MELD 3.0 demonstrates superior discrimination compared to MELD-Na in predicting waitlist mortality, with an improved C-statistic of 0.869 versus 0.862 for MELD-Na (p<0.01) 8

The American Association for the Study of Liver Diseases notes that MELD exceptions are still required for certain conditions, including hepatocellular carcinoma, hepatopulmonary syndrome, portopulmonary hypertension, and refractory ascites, as they are poorly captured by laboratory-based scoring 8